The Market Reports

Index

1 Friedreich Ataxia Drug Market Overview
1.1 Product Overview and Scope of Friedreich Ataxia Drug
1.2 Friedreich Ataxia Drug Segment by Type
1.2.1 Global Friedreich Ataxia Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 ADVM-063
1.2.3 AGIL-FA
1.2.4 BHV-4157
1.2.5 BVA-202
1.2.6 Others
1.3 Friedreich Ataxia Drug Segment by Application
1.3.1 Global Friedreich Ataxia Drug Sales Comparison by Application: (2021-2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Friedreich Ataxia Drug Market Size Estimates and Forecasts
1.4.1 Global Friedreich Ataxia Drug Revenue 2016-2027
1.4.2 Global Friedreich Ataxia Drug Sales 2016-2027
1.4.3 Friedreich Ataxia Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Friedreich Ataxia Drug Market Competition by Manufacturers
2.1 Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Friedreich Ataxia Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Friedreich Ataxia Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Friedreich Ataxia Drug Manufacturing Sites, Area Served, Product Type
2.5 Friedreich Ataxia Drug Market Competitive Situation and Trends
2.5.1 Friedreich Ataxia Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Friedreich Ataxia Drug Players Market Share by Revenue
2.5.3 Global Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Friedreich Ataxia Drug Retrospective Market Scenario by Region
3.1 Global Friedreich Ataxia Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Friedreich Ataxia Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Friedreich Ataxia Drug Market Facts & Figures by Country
3.3.1 North America Friedreich Ataxia Drug Sales by Country
3.3.2 North America Friedreich Ataxia Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Friedreich Ataxia Drug Market Facts & Figures by Country
3.4.1 Europe Friedreich Ataxia Drug Sales by Country
3.4.2 Europe Friedreich Ataxia Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Friedreich Ataxia Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Friedreich Ataxia Drug Sales by Region
3.5.2 Asia Pacific Friedreich Ataxia Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Friedreich Ataxia Drug Market Facts & Figures by Country
3.6.1 Latin America Friedreich Ataxia Drug Sales by Country
3.6.2 Latin America Friedreich Ataxia Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Friedreich Ataxia Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Friedreich Ataxia Drug Sales by Country
3.7.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Friedreich Ataxia Drug Historic Market Analysis by Type
4.1 Global Friedreich Ataxia Drug Sales Market Share by Type (2016-2021)
4.2 Global Friedreich Ataxia Drug Revenue Market Share by Type (2016-2021)
4.3 Global Friedreich Ataxia Drug Price by Type (2016-2021)

5 Global Friedreich Ataxia Drug Historic Market Analysis by Application
5.1 Global Friedreich Ataxia Drug Sales Market Share by Application (2016-2021)
5.2 Global Friedreich Ataxia Drug Revenue Market Share by Application (2016-2021)
5.3 Global Friedreich Ataxia Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Adverum Biotechnologies Inc
6.1.1 Adverum Biotechnologies Inc Corporation Information
6.1.2 Adverum Biotechnologies Inc Description and Business Overview
6.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Product Portfolio
6.1.5 Adverum Biotechnologies Inc Recent Developments/Updates
6.2 BioMarin Pharmaceutical Inc.
6.2.1 BioMarin Pharmaceutical Inc. Corporation Information
6.2.2 BioMarin Pharmaceutical Inc. Description and Business Overview
6.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product Portfolio
6.2.5 BioMarin Pharmaceutical Inc. Recent Developments/Updates
6.3 Biovista Inc.
6.3.1 Biovista Inc. Corporation Information
6.3.2 Biovista Inc. Description and Business Overview
6.3.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Biovista Inc. Friedreich Ataxia Drug Product Portfolio
6.3.5 Biovista Inc. Recent Developments/Updates
6.4 Cardero Therapeutics Inc
6.4.1 Cardero Therapeutics Inc Corporation Information
6.4.2 Cardero Therapeutics Inc Description and Business Overview
6.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Product Portfolio
6.4.5 Cardero Therapeutics Inc Recent Developments/Updates
6.5 Catabasis Pharmaceuticals, Inc.
6.5.1 Catabasis Pharmaceuticals, Inc. Corporation Information
6.5.2 Catabasis Pharmaceuticals, Inc. Description and Business Overview
6.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product Portfolio
6.5.5 Catabasis Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Forward Pharma A/S
6.6.1 Forward Pharma A/S Corporation Information
6.6.2 Forward Pharma A/S Description and Business Overview
6.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Forward Pharma A/S Friedreich Ataxia Drug Product Portfolio
6.6.5 Forward Pharma A/S Recent Developments/Updates
6.7 Ixchel Pharma LLC
6.6.1 Ixchel Pharma LLC Corporation Information
6.6.2 Ixchel Pharma LLC Description and Business Overview
6.6.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ixchel Pharma LLC Friedreich Ataxia Drug Product Portfolio
6.7.5 Ixchel Pharma LLC Recent Developments/Updates
6.8 Pfizer Inc
6.8.1 Pfizer Inc Corporation Information
6.8.2 Pfizer Inc Description and Business Overview
6.8.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pfizer Inc Friedreich Ataxia Drug Product Portfolio
6.8.5 Pfizer Inc Recent Developments/Updates
6.9 ProQR Therapeutics NV
6.9.1 ProQR Therapeutics NV Corporation Information
6.9.2 ProQR Therapeutics NV Description and Business Overview
6.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Product Portfolio
6.9.5 ProQR Therapeutics NV Recent Developments/Updates
6.10 RaNA Therapeutics Inc
6.10.1 RaNA Therapeutics Inc Corporation Information
6.10.2 RaNA Therapeutics Inc Description and Business Overview
6.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Product Portfolio
6.10.5 RaNA Therapeutics Inc Recent Developments/Updates
6.11 Reata Pharmaceuticals Inc
6.11.1 Reata Pharmaceuticals Inc Corporation Information
6.11.2 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Description and Business Overview
6.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product Portfolio
6.11.5 Reata Pharmaceuticals Inc Recent Developments/Updates
6.12 Retrotope Inc
6.12.1 Retrotope Inc Corporation Information
6.12.2 Retrotope Inc Friedreich Ataxia Drug Description and Business Overview
6.12.3 Retrotope Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Retrotope Inc Friedreich Ataxia Drug Product Portfolio
6.12.5 Retrotope Inc Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Corporation Information
6.13.2 Takeda Friedreich Ataxia Drug Description and Business Overview
6.13.3 Takeda Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Takeda Friedreich Ataxia Drug Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 STATegics Inc
6.14.1 STATegics Inc Corporation Information
6.14.2 STATegics Inc Friedreich Ataxia Drug Description and Business Overview
6.14.3 STATegics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.14.4 STATegics Inc Friedreich Ataxia Drug Product Portfolio
6.14.5 STATegics Inc Recent Developments/Updates
6.15 Voyager Therapeutics Inc
6.15.1 Voyager Therapeutics Inc Corporation Information
6.15.2 Voyager Therapeutics Inc Friedreich Ataxia Drug Description and Business Overview
6.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Voyager Therapeutics Inc Friedreich Ataxia Drug Product Portfolio
6.15.5 Voyager Therapeutics Inc Recent Developments/Updates

7 Friedreich Ataxia Drug Manufacturing Cost Analysis
7.1 Friedreich Ataxia Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Friedreich Ataxia Drug
7.4 Friedreich Ataxia Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Friedreich Ataxia Drug Distributors List
8.3 Friedreich Ataxia Drug Customers

9 Friedreich Ataxia Drug Market Dynamics
9.1 Friedreich Ataxia Drug Industry Trends
9.2 Friedreich Ataxia Drug Growth Drivers
9.3 Friedreich Ataxia Drug Market Challenges
9.4 Friedreich Ataxia Drug Market Restraints

10 Global Market Forecast
10.1 Friedreich Ataxia Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Friedreich Ataxia Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Friedreich Ataxia Drug by Type (2022-2027)
10.2 Friedreich Ataxia Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Friedreich Ataxia Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Friedreich Ataxia Drug by Application (2022-2027)
10.3 Friedreich Ataxia Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Friedreich Ataxia Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Friedreich Ataxia Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Friedreich Ataxia Drug Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Friedreich Ataxia Drug Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Friedreich Ataxia Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Friedreich Ataxia Drug Covered in This Study
Table 5. Global Friedreich Ataxia Drug Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Friedreich Ataxia Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Friedreich Ataxia Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Friedreich Ataxia Drug Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Friedreich Ataxia Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Friedreich Ataxia Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Friedreich Ataxia Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Friedreich Ataxia Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Friedreich Ataxia Drug Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Friedreich Ataxia Drug Sales Market Share by Region (2016-2021)
Table 17. Global Friedreich Ataxia Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Friedreich Ataxia Drug Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Friedreich Ataxia Drug Sales Market Share by Country (2016-2021)
Table 20. North America Friedreich Ataxia Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Friedreich Ataxia Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Friedreich Ataxia Drug Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Friedreich Ataxia Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Friedreich Ataxia Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Friedreich Ataxia Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Friedreich Ataxia Drug Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Friedreich Ataxia Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Friedreich Ataxia Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Friedreich Ataxia Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Friedreich Ataxia Drug Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Friedreich Ataxia Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Friedreich Ataxia Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Friedreich Ataxia Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Friedreich Ataxia Drug Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Friedreich Ataxia Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Friedreich Ataxia Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Friedreich Ataxia Drug Sales (K Pcs) by Type (2016-2021)
Table 39. Global Friedreich Ataxia Drug Sales Market Share by Type (2016-2021)
Table 40. Global Friedreich Ataxia Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Friedreich Ataxia Drug Revenue Share by Type (2016-2021)
Table 42. Global Friedreich Ataxia Drug Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Friedreich Ataxia Drug Sales (K Pcs) by Application (2016-2021)
Table 44. Global Friedreich Ataxia Drug Sales Market Share by Application (2016-2021)
Table 45. Global Friedreich Ataxia Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Friedreich Ataxia Drug Revenue Share by Application (2016-2021)
Table 47. Global Friedreich Ataxia Drug Price (USD/Pcs) by Application (2016-2021)
Table 48. Adverum Biotechnologies Inc Corporation Information
Table 49. Adverum Biotechnologies Inc Description and Business Overview
Table 50. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product
Table 52. Adverum Biotechnologies Inc Recent Developments/Updates
Table 53. BioMarin Pharmaceutical Inc. Corporation Information
Table 54. BioMarin Pharmaceutical Inc. Description and Business Overview
Table 55. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product
Table 57. BioMarin Pharmaceutical Inc. Recent Developments/Updates
Table 58. Biovista Inc. Corporation Information
Table 59. Biovista Inc. Description and Business Overview
Table 60. Biovista Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Biovista Inc. Friedreich Ataxia Drug Product
Table 62. Biovista Inc. Recent Developments/Updates
Table 63. Cardero Therapeutics Inc Corporation Information
Table 64. Cardero Therapeutics Inc Description and Business Overview
Table 65. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Cardero Therapeutics Inc Friedreich Ataxia Drug Product
Table 67. Cardero Therapeutics Inc Recent Developments/Updates
Table 68. Catabasis Pharmaceuticals, Inc. Corporation Information
Table 69. Catabasis Pharmaceuticals, Inc. Description and Business Overview
Table 70. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product
Table 72. Catabasis Pharmaceuticals, Inc. Recent Developments/Updates
Table 73. Forward Pharma A/S Corporation Information
Table 74. Forward Pharma A/S Description and Business Overview
Table 75. Forward Pharma A/S Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Forward Pharma A/S Friedreich Ataxia Drug Product
Table 77. Forward Pharma A/S Recent Developments/Updates
Table 78. Ixchel Pharma LLC Corporation Information
Table 79. Ixchel Pharma LLC Description and Business Overview
Table 80. Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Ixchel Pharma LLC Friedreich Ataxia Drug Product
Table 82. Ixchel Pharma LLC Recent Developments/Updates
Table 83. Pfizer Inc Corporation Information
Table 84. Pfizer Inc Description and Business Overview
Table 85. Pfizer Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Pfizer Inc Friedreich Ataxia Drug Product
Table 87. Pfizer Inc Recent Developments/Updates
Table 88. ProQR Therapeutics NV Corporation Information
Table 89. ProQR Therapeutics NV Description and Business Overview
Table 90. ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. ProQR Therapeutics NV Friedreich Ataxia Drug Product
Table 92. ProQR Therapeutics NV Recent Developments/Updates
Table 93. RaNA Therapeutics Inc Corporation Information
Table 94. RaNA Therapeutics Inc Description and Business Overview
Table 95. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. RaNA Therapeutics Inc Friedreich Ataxia Drug Product
Table 97. RaNA Therapeutics Inc Recent Developments/Updates
Table 98. Reata Pharmaceuticals Inc Corporation Information
Table 99. Reata Pharmaceuticals Inc Description and Business Overview
Table 100. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product
Table 102. Reata Pharmaceuticals Inc Recent Developments/Updates
Table 103. Retrotope Inc Corporation Information
Table 104. Retrotope Inc Description and Business Overview
Table 105. Retrotope Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Retrotope Inc Friedreich Ataxia Drug Product
Table 107. Retrotope Inc Recent Developments/Updates
Table 108. Takeda Corporation Information
Table 109. Takeda Description and Business Overview
Table 110. Takeda Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Takeda Friedreich Ataxia Drug Product
Table 112. Takeda Recent Developments/Updates
Table 113. STATegics Inc Corporation Information
Table 114. STATegics Inc Description and Business Overview
Table 115. STATegics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. STATegics Inc Friedreich Ataxia Drug Product
Table 117. STATegics Inc Recent Developments/Updates
Table 118. Voyager Therapeutics Inc Corporation Information
Table 119. Voyager Therapeutics Inc Description and Business Overview
Table 120. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Voyager Therapeutics Inc Friedreich Ataxia Drug Product
Table 122. Voyager Therapeutics Inc Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Friedreich Ataxia Drug Distributors List
Table 126. Friedreich Ataxia Drug Customers List
Table 127. Friedreich Ataxia Drug Market Trends
Table 128. Friedreich Ataxia Drug Growth Drivers
Table 129. Friedreich Ataxia Drug Market Challenges
Table 130. Friedreich Ataxia Drug Market Restraints
Table 131. Global Friedreich Ataxia Drug Sales Forecast by Type (2022-2027) & (K Pcs)
Table 132. Global Friedreich Ataxia Drug Sales Market Share Forecast by Type (2022-2027)
Table 133. Global Friedreich Ataxia Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 134. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Type (2022-2027)
Table 135. Global Friedreich Ataxia Drug Sales Forecast by Application (2022-2027) & (K Pcs)
Table 136. Global Friedreich Ataxia Drug Sales Market Share Forecast by Application (2022-2027)
Table 137. Global Friedreich Ataxia Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 138. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Application (2022-2027)
Table 139. Global Friedreich Ataxia Drug Sales Forecast by Region (2022-2027) & (K Pcs)
Table 140. Global Friedreich Ataxia Drug Sales Market Share Forecast by Region (2022-2027)
Table 141. Global Friedreich Ataxia Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 142. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Region (2022-2027)
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Friedreich Ataxia Drug
Figure 2. Global Friedreich Ataxia Drug Market Share by Type in 2020 & 2027
Figure 3. ADVM-063 Product Picture
Figure 4. AGIL-FA Product Picture
Figure 5. BHV-4157 Product Picture
Figure 6. BVA-202 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Friedreich Ataxia Drug Market Share by Application in 2020 & 2027
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Friedreich Ataxia Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Friedreich Ataxia Drug Market Size 2016-2027 (US$ Million)
Figure 14. Global Friedreich Ataxia Drug Sales 2016-2027 (K Pcs)
Figure 15. Global Friedreich Ataxia Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Friedreich Ataxia Drug Sales Share by Manufacturers in 2020
Figure 17. Global Friedreich Ataxia Drug Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Friedreich Ataxia Drug Players: Market Share by Revenue in 2020
Figure 19. Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Friedreich Ataxia Drug Sales Market Share by Region (2016-2021)
Figure 21. Global Friedreich Ataxia Drug Sales Market Share by Region in 2020
Figure 22. Global Friedreich Ataxia Drug Revenue Market Share by Region (2016-2021)
Figure 23. Global Friedreich Ataxia Drug Revenue Market Share by Region in 2020
Figure 24. U.S. Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Friedreich Ataxia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Friedreich Ataxia Drug by Type (2016-2021)
Figure 49. Sales Market Share of Friedreich Ataxia Drug by Application (2016-2021)
Figure 50. Sales Market Share of Friedreich Ataxia Drug by Application in 2020
Figure 51. Revenue Share of Friedreich Ataxia Drug by Application (2016-2021)
Figure 52. Revenue Share of Friedreich Ataxia Drug by Application in 2020
Figure 53. Manufacturing Cost Structure of Friedreich Ataxia Drug
Figure 54. Manufacturing Process Analysis of Friedreich Ataxia Drug
Figure 55. Friedreich Ataxia Drug Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed